Hjem › Anæmi › Texas › Houston
Anæmi kliniske forsøg i Houston, TX
5 studier for Anæmi søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
RekruttererFase 3
- MD Anderson Cancer Center, Houston
- The University of Utah-Huntsman Cancer Institute, Houston
- LUMI Research, Houston
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RekruttererFase 1/2
- MD Anderson, Houston
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RekruttererFase 3
- The University of Texas-MD Anderson Cancer Center - Leukemia Center, Houston
- LUMI Research, Houston
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RekruttererFase 3
- U.T. MD Anderson Cancer Center, Division of Cancer Medicine, Houston
A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
Rekrutterer
- The University of Texas Health Science Center at Houston, Houston
Anæmi forsøg i andre byer
- New York City, NY7 studier
- Miami, FL6 studier
- Atlanta, GA6 studier
- Philadelphia, PA6 studier
- Tampa, FL5 studier
- Winston-Salem, NC4 studier
- Cleveland, OH4 studier
- Baldwin Park, CA4 studier
- St. Louis, MO4 studier
- Queens, NY3 studier
- Nashville, TN3 studier
- The Woodlands, TX3 studier
Andre studier i Houston
- Ikke-småcellet lungecancer145 studier
- Brystkræft126 studier
- Kræft (alle typer)121 studier
- Metastatisk cancer104 studier
- Colorektal kræft102 studier
- Ægstockræft89 studier
- Akut myeloid leukæmi85 studier
- Lungecancer78 studier
- Prostatakræft76 studier
- Livmoderslimhindekræft68 studier
- Bugspytkirtelkræft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.